{
  "docId": "019de076-2351-76a2-9dc5-1c75bf1dd158",
  "docSlug": "905d9ceaf5cb608feb86b583a8401e54",
  "documentTitle": "AstraZeneca | Results Presentation Deck | 45 slides",
  "authorId": "astrazeneca",
  "authorName": "AstraZeneca",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 34,
  "pageCount": 45,
  "prevPage": 33,
  "nextPage": 35,
  "slideType": "appendix_data",
  "function": "summarize",
  "density": "dense",
  "nDataPoints": 9,
  "notes": "The slide uses color coding to distinguish between therapeutic areas: Oncology (dark purple), BioPharmaceuticals (light blue), and Rare Disease (magenta).",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-2351-76a2-9dc5-1c75bf1dd158/34",
  "deckHref": "/decks/019de076-2351-76a2-9dc5-1c75bf1dd158",
  "deckJsonHref": "/decks/019de076-2351-76a2-9dc5-1c75bf1dd158.json",
  "deckAnchorHref": "/decks/019de076-2351-76a2-9dc5-1c75bf1dd158#slide-34",
  "components": [
    {
      "bbox": {
        "h": 0.04,
        "w": 0.85,
        "x": 0.03,
        "y": 0.95
      },
      "kind": "disclaimer",
      "text": "EGFRm = epidermal growth factor receptor-mutated; HER2 = human epidermal growth factor receptor 2; HER2m = human epidermal growth factor receptor 2-mutated; NSCLC = non-small cell lung cancer; CLL = chronic lymphocytic leukaemia; HFpEF = heart failure with preserved ejection fraction. Collaboration partners: Daiichi Sankyo (Enhertu), Merck & Co., Inc. (Lynparza).",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fef4635e-efda-4b15-a30f-19044ba1f322",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.22,
        "x": 0.18,
        "y": 0.27
      },
      "kind": "list",
      "text": "3 Breakthrough Designations (US): Tagrisso, Enhertu (x2)",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "503b747e-7554-43a8-8b52-ec7ee141fa6e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.55,
        "w": 0.45,
        "x": 0.43,
        "y": 0.27
      },
      "kind": "list",
      "text": "6 regulatory approvals in major markets: Lynparza, Enhertu, Calquence, Forxiga, Soliris",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5e473617-0b27-45dd-8de0-65ef0bb451cc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.55,
        "x": 0.03,
        "y": 0.07
      },
      "kind": "title",
      "text": "Delivering on science-led innovation",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ff3e4d02-a348-4dfa-9ccf-fd1f115363c6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.45,
        "x": 0.03,
        "y": 0.14
      },
      "kind": "title",
      "text": "Selected key pipeline highlights since Q2 2023 Results",
      "attrs": null,
      "subkind": "subtitle",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "50007294-8a42-42e5-9d22-dd0545d918ee",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "80f85c4c-8be3-425f-8296-d0ca86eb7f21",
      "evidence": "list/bullet: 6 regulatory approvals in major markets: Lynparza, Enhertu, Calquence, Forxiga, Soliris",
      "confidence": 0.8
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}